Effects of amantadine withdrawal after long-term use in Parkinson's disease

被引：0
|
作者：
Akhtar, F.
Rajput, M. L.
Rajput, A.
Rajput, A. H.
机构：
来源：
MOVEMENT DISORDERS | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
825
引用
收藏
页码：S277 / S278
页数：2
相关论文
共 50 条
  • [11] Long-term effects of amantadine in parkinsonian
    Magne, F. Ory
    Thalamas, C.
    Galitzky, M.
    Salis, A.
    Sommet, A.
    Pourcel, L.
    Azulay, J. P.
    Damier, P.
    Destee, A.
    Durif, F.
    Lacomblez, L.
    Tison, F.
    Viallet, F.
    Rascol, O.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 68 - 68
  • [12] SUDDEN WITHDRAWAL OF PROPRANOLOL AFTER LONG-TERM USE
    不详
    SOUTH AFRICAN MEDICAL JOURNAL, 1978, 54 (25): : 1040 - 1041
  • [13] Antidyskinetic actions of amantadine in Parkinson's disease: are benefits maintained in the long term?
    Brotchie, Jonathan
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (06) : 871 - 873
  • [14] Long-term course of Parkinson's disease
    Ebersbach, G.
    NERVENHEILKUNDE, 2010, 29 (06) : 345 - 350
  • [15] Long-term effects of deep brain stimulation in Parkinson's disease
    Freund, HJ
    BRAIN, 2005, 128 : 2222 - 2223
  • [16] Structural underpinnings and long-term effects of resilience in Parkinson's disease
    Dzialas, Verena
    Hoenig, Merle C.
    Prange, Stephane
    Bischof, Gerard N.
    Drzezga, Alexander
    van Eimeren, Thilo
    NPJ PARKINSONS DISEASE, 2024, 10 (01)
  • [17] Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease
    Cattaneo, Carlo
    Mueller, Thomas
    Bonizzoni, Erminio
    Lazzeri, Gabriele
    Kottakis, Ioannis
    Keywood, Charlotte
    JOURNAL OF PARKINSONS DISEASE, 2017, 7 (04) : 629 - 634
  • [18] Long-term effects of bilateral subthalamic stimulation in Parkinson's disease
    Bruno, V.
    Cavanagh, S.
    Lloret, S. Perez
    Merello, M.
    MOVEMENT DISORDERS, 2008, 23 (01) : S118 - S118
  • [19] Long-term effects of air pollution on the risk of Parkinson's disease
    Hwang, Y. S.
    Jo, S. Y.
    Kim, Y. J.
    Park, K. W.
    Lee, S. H.
    Chung, S. J.
    MOVEMENT DISORDERS, 2020, 35 : S366 - S366
  • [20] Long-Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease
    Pagan, Fernando L.
    Wilmarth, Barbara
    Torres-Yaghi, Yasar
    Hebron, Michaeline L.
    Mulki, Sanjana
    Ferrante, Dalila
    Matar, Sara
    Ahn, Jaeil
    Moussa, Charbel
    MOVEMENT DISORDERS, 2021, 36 (03) : 740 - 749
12345